Natixis Advisors LLC decreased its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 13.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 260,842 shares of the financial services provider’s stock after selling 39,788 shares during the quarter. Natixis Advisors LLC’s holdings in Aflac were worth $26,981,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of AFL. Whipplewood Advisors LLC acquired a new stake in shares of Aflac during the fourth quarter worth $26,000. Darwin Wealth Management LLC acquired a new stake in Aflac during the 3rd quarter worth about $34,000. BankPlus Trust Department purchased a new stake in Aflac during the fourth quarter valued at about $34,000. Raelipskie Partnership acquired a new position in shares of Aflac in the third quarter worth about $38,000. Finally, OFI Invest Asset Management purchased a new position in shares of Aflac in the fourth quarter worth approximately $38,000. Institutional investors own 67.44% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Morgan Stanley lifted their price target on Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Evercore ISI lowered their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Finally, Keefe, Bruyette & Woods reduced their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $103.36.
Aflac Trading Up 1.1 %
Aflac stock opened at $108.47 on Tuesday. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The company’s fifty day moving average price is $105.51 and its two-hundred day moving average price is $107.67. The company has a market capitalization of $59.29 billion, a price-to-earnings ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Insider Transactions at Aflac
In related news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares in the company, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is owned by insiders.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- How to Read Stock Charts for Beginners
- Can TikTok Stock Picks Really Make You Rich?
- Canada Bond Market Holiday: How to Invest and Trade
- The “Quality” Rotation: Back to Basics Investing
- How to Use the MarketBeat Stock Screener
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.